Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

3D-organoid culture supports differentiation of human CAR+ iPSCs into highly functional CAR T cells
Zhiqiang Wang, Helen P. McWilliams-Koeppen, Hernan Reza, et al.
Cell stem cell (2022) Vol. 29, Iss. 4, pp. 515-527.e8
Open Access | Times Cited: 94

Showing 26-50 of 94 citing articles:

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
Piotr Celichowski, Marcello Turi, Sandra Charvátová, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
Caroline Diorio, David T. Teachey, Stephan A. Grupp
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 8
Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Franco Locatelli, Francesca Del Bufalo, Concetta Quintarelli
Haematologica (2024) Vol. 109, Iss. 6, pp. 1689-1699
Open Access | Times Cited: 6
Advances in CAR‐Engineered Immune Cell Generation: Engineering Approaches and Sourcing Strategies
Zhaozhao Chen, Yu Hu, Heng Mei
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 16
The beta cell-immune cell interface in type 1 diabetes (T1D)
Eddie A. James, Alok V. Joglekar, Amelia K. Linnemann, et al.
Molecular Metabolism (2023) Vol. 78, pp. 101809-101809
Open Access | Times Cited: 15
Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells
Suwen Li, Chloe S. Wang, Amélie Montel‐Hagen, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112241-112241
Open Access | Times Cited: 13
Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy
Teng Zhang, Cheng Qian, Mengyao Song, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2680-2680
Open Access | Times Cited: 5
In vivo manufacture and manipulation of CAR-T cells for better druggability
Rui Hou, Xiaoxue Zhang, Xu Wang, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1075-1093
Closed Access | Times Cited: 5
The role of GATA2 in adult hematopoiesis and cell fate determination
Iris J. A. Peters, Emma de Pater, Wei Zhang
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 12
Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy
Yingfeng Zhang, Yuanyuan He, Chenyi Dai, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 9, pp. 100843-100843
Open Access | Times Cited: 4
iPSC Technology Revolutionizes CAR-T Cell Therapy for Cancer Treatment
Jiepu Zong, Yan-Ruide Li
Bioengineering (2025) Vol. 12, Iss. 1, pp. 60-60
Open Access
Pluripotent stem cell-based immunotherapy: advances in translational research, cell differentiation, and gene modifications
Qi Lei, Hongkui Deng, Shicheng Sun
Life Medicine (2025) Vol. 4, Iss. 1
Open Access
The development and potent antitumor efficacy of CD44/CD133 dual-targeting IL7Rα-armored CAR-T cells against glioblastoma
You Zhai, Guanzhang Li, Changqing Pan, et al.
Cancer Letters (2025) Vol. 614, pp. 217541-217541
Closed Access
hiPSC-Driven Organoid Construction and Application Prospects
Bangheng Liu, Yulei Mu, Dong‐An Wang
Regenerative medicine and dentistry. (2025), pp. 5-5
Closed Access
The clinical landscape of CAR-engineered unconventional T cells
Yan-Ruide Li, Yichen Zhu, Yuning Chen, et al.
Trends in cancer (2025)
Open Access
Organoid Models of Lymphoid Tissues
Ania Bogoslowski, Jun Ren, Clément Quintard, et al.
Organoids (2025) Vol. 4, Iss. 2, pp. 7-7
Open Access
Cell therapies against brain tumors: Clinical development and emerging prospects
Tatsuya Fukuta, Suyog Shaha, Andrés da Silva‐Candal, et al.
Bioengineering & Translational Medicine (2025)
Open Access
CAR-T treatment for cancer: prospects and challenges
Ran Chen, Lei Chen, Chaoqun Wang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Applications of lung cancer organoids in precision medicine: from bench to bedside
Huihui Li, Zexin Chen, Ning Chen, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Organoid co‐culture models of the tumor microenvironment promote precision medicine
Zhaoru Gu, Quanyou Wu, Bingqing Shang, et al.
Cancer Innovation (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 9
Lymphocyte homing and recirculation with tumor tertiary lymphoid structure formation: predictions for successful cancer immunotherapy
Weihong Tian, Wangzhi Wei, Gaofeng Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review
Chaozhi Tang, Yuling Zhang
Pathology - Research and Practice (2024) Vol. 262, pp. 155518-155518
Closed Access | Times Cited: 3
Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
Di Chen, Lixia Xu, Mengjuan Xuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 3
Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects
Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
Enhancing CAR T-cell therapies against solid tumors: Mechanisms and reversion of resistance
Yue Qin, Guotai Xu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15

Scroll to top